惠云钛业(300891) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥472,538,473.85, representing a 15.09% increase compared to ¥410,580,810.78 in the same period last year[5]. - The net profit attributable to shareholders decreased significantly by 98.40% to ¥465,789.62 from ¥29,073,908.83 year-on-year[5]. - The net profit for the current period was ¥522,684.80, a significant decrease of 98.2% from ¥29,073,908.83 in the previous period[20]. - The company experienced a decrease in diluted earnings per share by 98.35% to ¥0.0012 from ¥0.0727 in the previous year[5]. - Basic and diluted earnings per share decreased to ¥0.0012 from ¥0.0727 in the previous period, reflecting the decline in profitability[20]. Cash Flow - The net cash flow from operating activities was negative at -¥6,212,474.55, a decline of 533.73% compared to ¥1,432,339.48 in the previous year[5]. - The net cash flow from operating activities was negative at -¥6,212,474.55, compared to a positive cash flow of ¥1,432,339.48 in the previous period[22]. - The net cash flow from investing activities was -¥78,160,123.20, reflecting increased cash outflows for fixed asset purchases and ongoing construction projects[10]. - The company reported a net cash outflow from investing activities of -¥78,160,123.20, compared to -¥11,371,316.01 in the previous period, indicating increased investment expenditures[23]. - The net cash flow from financing activities was -¥3,764,349.85, a decrease from a positive cash flow of ¥15,627,990.12 in the previous period, suggesting tighter financing conditions[24]. Assets and Liabilities - The total assets at the end of Q1 2023 were ¥2,489,994,391.00, an increase of 1.72% from ¥2,447,893,199.66 at the end of the previous year[5]. - The company's current assets decreased to CNY 1,273,698,421.58 from CNY 1,367,485,538.78, reflecting a decline of approximately 6.9%[16]. - The total liabilities rose to CNY 1,146,242,624.48 from CNY 1,104,965,943.89, marking an increase of about 3.7%[17]. - The company's total equity as of March 31, 2023, was CNY 1,343,751,766.52, slightly up from CNY 1,342,927,255.77[17]. Accounts and Inventory - Accounts receivable increased by 99.69% to ¥139,224,654.16 due to higher sales revenue, while inventory decreased by 23.68% to ¥275,825,884.76[8]. - Accounts receivable increased significantly to CNY 139,224,654.16 from CNY 69,720,928.26, representing a growth of approximately 99.5%[16]. - Inventory decreased to CNY 275,825,884.76 from CNY 361,405,176.78, indicating a decline of about 23.6%[16]. Expenses - Financial expenses surged by 3,324.47% to ¥2,442,007.07, primarily due to increased interest from short-term loans and convertible bonds[9]. - Research and development expenses rose to ¥12,029,810.93, an increase of 15.5% compared to ¥10,411,311.14 in the previous period, indicating a focus on innovation[19]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,381, with the top three shareholders holding a combined 61.95% of the shares[12]. Other Developments - The company has made progress on several fundraising projects and established a doctoral workstation in Guangdong Province, as disclosed in their recent announcements[14].